Products

Signal Tracker Data Platform Data Enrichment API Intelligence desk

Solutions

Inward Investment & Aftercare Deal Origination Executive Search Corporate Development Signal-Based Outbound Competitive Intelligence Funding Signals Competitor Monitoring For Sales Teams For Founders For Agencies For Investors

Explore

Companies Live Signals Markets Trends

Resources

Signal Checker Blog Integrations FAQ Contact Pricing
Login Book a demo
Nurami Medical logo — Revolutionizing Soft Tissue Repair

Nurami Medical

Revolutionizing Soft Tissue Repair

Founded 2014 Israel Israel 20 employees Grant Total: $11.00M Health Care, Medical Devices

General Information

Company Name Nurami Medical
Founded Year 2014
Location Israel Israel
Employees 20
Industries Health Care, Medical Devices
Funding Stage Grant
Social

BounceWatch is an independent company data service, not affiliated with Nurami Medical. To contact Nurami Medical, visit nurami-medical.com.

Is this your company?

Confirm with your work e-mail, get the Verified badge and keep this profile correct yourself. Search engines and AI assistants read it every day.

Get Verified

About Nurami Medical

Nurami Medical is an early commercial stage company with the slogan "Revolutionizing Soft Tissue Repair." The company is focused on revolutionizing next-generation surgical products for the repair, regeneration, and safe healing of soft tissues following internal surgeries. Their emphasis is on unique formulations of biomaterials and electrospun nanofiber-based bio-mimetic scaffolds. Their first product, ArtiFascia®, is an advanced, multi-layer, biomimetic dura repair patch designed to improve Dura repair in neurosurgeries. It is FDA-cleared (510K) for use in Dura repair. Nurami Medical was founded in 2014 and is headquartered in Israel. The company received a €2.50M grant investment from EIC Accelerator on July 13, 2024. Nurami Medical operates in the Health Care and Medical Devices industries. For more information, visit their media channels at Terms of use of our media channels.

Taxonomy: Soft Tissue Repair, Biomaterials, Nanofiber-based Scaffolds, Dura Repair Patch, Neurosurgery, Surgical Products, Regenerative Medicine, Electrospinning Technology, Internal Surgeries

Services & Products

Development and commercialization of nanofiber-based biomaterials and surgical implants for soft tissue repair and regenerative medicine

Target Customers

Medical professionals hospitals surgical centers and patients in need of soft tissue repair and regenerative solutions

Funding Rounds & Investors (6)

View All
Funding Stage Amount Investors Lead Investors Date
Funding Round Undisclosed -
13 Jul 2024
Grant €2.50M 1
EIC Accelerator
13 Jul 2024
Non Equity Assistance Undisclosed 1
MedTech Innovator
MedTech Innovator
29 May 2024
Series A $6.00M 2
GlenRock Israel, Alameda Ventures
02 Nov 2020
Venture Round Undisclosed 1
Almeda Capital
Almeda Capital
01 Nov 2020
Venture Round ILS2.50M 1
huMannity Medtec
21 Dec 2016

Nurami Medical Alternatives & Competitors

View All Alternatives
Nurami Medical vs
Serica
Serica

Serica is a growth-stage medical device company focused on the development of silk-based biomaterial...

Series C
15 employees
Biotechnology, Health Care
Nurami Medical vs
Axolotl Biosystems
Axolotl Biosystems Turkey

Axolotl Biosystems creates and engineers regenerative medicine and tissue engineering products and s...

4 employees
Biotechnology, Health Care
Nurami Medical vs
Tepha, Inc.
Tepha, Inc. United States

The next generation of Implantable polymers. Resorbable and Regenerative.

Debt Financing
13 employees
Biotechnology, Health Care
View all alternatives

FAQ About Nurami Medical

Revolutionizing Soft Tissue Repair
Nurami Medical was founded in 2014.
Nurami Medical is headquartered in Israel.
Nurami Medical operates in Health Care and Medical Devices. Its work centres on Soft Tissue Repair, Biomaterials, Nanofiber-based Scaffolds and Dura Repair Patch. Its customers include Medical professionals, hospitals and surgical centers.
Nurami Medical has approximately 20 employees.
Nurami Medical has completed 6 funding rounds, raising a total of $11.00M. The latest funding stage is Grant.
Nurami Medical offers: Development and commercialization of nanofiber-based biomaterials and surgical implants for soft tissue repair and regenerative medicine.
Top alternatives and competitors to Nurami Medical include Serica, Axolotl Biosystems, Tepha, Inc., LATTICE MEDICAL, CoNextions Medical. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
Nurami Medical and Serica are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Source: BounceWatch company record for Nurami Medical, https://bouncewatch.com/company/nurami-medical, updated 3 March 2025. When citing, please name BounceWatch and link this page.

Analytics cookies (ours + Google). Cookie Policy

Book a demo 30 minutes